EARLY Intervention in Parent-professional Cooperation in Cerebral Palsy
PRECOP
Impact of a Screening and Early Intervention Program on the Functional Impact of Cerebral Palsy at 2 Years in Children at High Risk of Cerebral Palsy: a Prospective Comparative Multicenter Study.
1 other identifier
interventional
66
1 country
8
Brief Summary
Cerebral Palsy (CP) is the most common motor disability in children. It is due to damage that occurs during brain development in the fetus or infant. Early treatment (before 2 years) will allow the child to promote brain plasticity to compensate for the effects of the lesion and reduce the severity of CP. The goals of early intervention are to increase motor, cognitive and communication skills, prevent complications and provide parental support. Most authors agree to recognize the benefit of early care by emphasizing home intervention programs with active parental participation. To date, no recommendations exist in France for the management of cerebral palsy in children under the age of two. It is therefore necessary to conduct scientific studies in this population. Based on published international studies, the PRECOP program (PREcoce intervention in parent-professional COoperation in Cerebral Palsy) consists of individualized care adapted to the specific needs of each child, from the arrival of the infant at home, by a multidisciplinary team during the child's first two years.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2025
Longer than P75 for not_applicable
8 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 23, 2023
CompletedFirst Posted
Study publicly available on registry
December 22, 2023
CompletedStudy Start
First participant enrolled
March 14, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 14, 2029
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 14, 2029
April 24, 2026
April 1, 2026
4.5 years
October 23, 2023
April 21, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Score of the Total Motor Index at PDMS-3 scale (Peabody Developmental Motor Scales).
Score of the Total Motor Index at PDMS-3 scale (Peabody Developmental Motor Scales).The Total Motor Index results from the combination of Gross Motor Index and Fine Motor Index scores at PDMS-3. The functional impact of cerebral palsy at 2 years is assessed by the PDMS-3 at 24 months of age will be estimated in each of the two groups by a mean value with a 95% confidence interval.
24 months
Secondary Outcomes (14)
Motor development
24 months
Cognitive development
24 months
Nutritional development
24 months
Development of Production Language in French (DLPF) questionnaire
24 months
Early relational problems
24 months
- +9 more secondary outcomes
Study Arms (2)
Intervention group
EXPERIMENTALPRECOP group: screening and early treatment. CAMSP (Centre d'Action Médico-Sociale Précoce) orientation upon discharge from neonatology for immediate follow-up according to PRECOP protocol: early multidisciplinary care, with targeted objectives according to the child's needs.
Control group
NO INTERVENTIONStandard of care group: in the control centers, care includes specialized consultations organized by the perinatal network with a hospital and/or community pediatrician belonging to the network until the child is 2 years old. Cerebral palsy screening is based on clinical examination.
Interventions
PRECOP program is the first program combining early detection of cerebral palsy with implementation of early interventions following the latest international recommendations (multidisciplinary program at home, with the possibility of intensive courses, coaching parental, in the first 2 years of life). This comprehensive monitoring is implemented as soon as the infant arrives at home, by a multidisciplinary team and continues during the child's first 2 years. It includes: * Follow-up organized primarily at home * Monitoring of psychomotor development * Screening for possible cerebral palsy * Comprehensive support for the child's development: weight, diet, sleep... * Reeducation, implementation of SMART type objectives (Specific, Measurable, Achievable, Achievable, Timely defined) determined with parents * Creation of equipment if necessary: early seating installation in particular * Parental support and guidance for optimizing early care * Parental psychological support.
Eligibility Criteria
You may qualify if:
- New born presenting on transfontanellar ultrasound and confirmed on brain MRI (magnetic resonance imaging) at least one of the following brain lesions at high risk of cerebral palsy :
- Stage 3 intraventricular hemorrhage, requiring at least 2 subtractive lumbar punctures and/or the establishment of a ventriculoperitoneal bypass
- Stage 4 intraventricular hemorrhage
- Periventricular leukomalacia : extensive unilateral or bilateral
- Sequelae of perinatal anoxo-ischemic encephalopathy
- Extensive neonatal stroke
- Less than 3 months old (corrected age in case of prematurity)
- Hospitalized in neonatology or hospitalized in pediatric intensive care unit or within two months following return home (follow-up visit after initial hospitalization)
- Affiliate to social security
- Parental or legal representative consent to participate in the study (free and informed written consent)
You may not qualify if:
- Children who have had an Antenatal Diagnosis of a pathology causing fear of the onset of developmental delay
- Children presenting with a congenital pathology with neonatal revelation, whether of metabolic, genetic or malformative origin
- Palliative care offered by the neonatology team (LATA: Limitation and Discontinuation of Active Therapeutics)
- Children participating simultaneously in another screening and early care program (excluding the COCON program (Soins préCOces et COordonnés du Nouveau-né vulnérable))
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (8)
CH de Annecy
Annecy, 74370, France
Service de Réanimation et médecine néonatale
Chambéry, 73011, France
Service de Réanimation Néonatale, Hôpital de la Croix-Rousse, Hospices Civils de Lyon
Lyon, 69317, France
Service de néonatologie et de réanimation néonatale, Hôpital Femme Mère Enfant, Hospices Civils de Lyon
Lyon, 69677, France
Service de néonatologie et de réanimation néonatale, CHU Saint-ELOI
Montpellier, 34295, France
Service de néonatologie et de réanimation néonatale, Hôpital Universitaire Carémeau
Nîmes, 30029, France
Service de réanimation pédiatrique, Hôpital des enfants
Toulouse, 31059, France
Service de néonatologie, Hôpital des enfants
Toulouse, 31300, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Virginie MOURON, MD
Service de Réanimation Néonatale, Hôpital de la Croix-Rousse, Hospices Civils de Lyon
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- SCREENING
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 23, 2023
First Posted
December 22, 2023
Study Start
March 14, 2025
Primary Completion (Estimated)
September 14, 2029
Study Completion (Estimated)
September 14, 2029
Last Updated
April 24, 2026
Record last verified: 2026-04